CAXTON CORP

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1388551 Princeton, NJ

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$110,011

-$51,999 QoQ

Shares Held

12,347

-34.2% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

6.79%

of 13F equity value

Holder Rank

#82

of 120 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CAXTON CORP holds $362,737 across 5 Biotechnology names. KYTX ranks #1 (30.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYTX	Kyverna Therapeutics, Inc. This page	12,347	$110,011
2	LXEO	Lexeo Therapeutics, Inc.	16,962	$78,958
3	XFOR	X4 Pharmaceuticals, Inc	15,557	$72,651
4	IKT	Inhibikase Therapeutics, Inc.	28,453	$57,759
5	ALXO	Alx Oncology Holdings Inc	20,946	$43,358

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$110,011	12,347	-34.2%	Shares	Sole	2026-08-14
2026-03-31	$162,010	18,773	0.0%	Shares	Sole	2026-05-14
2025-12-31	$176,466	18,773	-18.3%	Shares	Sole	2026-02-13
2025-09-30	$137,886	22,981	0.0%	Shares	Sole	2025-11-14
2025-06-30	$70,551	22,981	0.0%	Shares	Sole	2025-08-14
2025-03-31	$44,353	22,981	0.0%	Shares	Sole	2025-05-15
2024-12-31	$85,948	22,981	0.0%	Shares	Sole	2025-02-14
2024-09-30	$112,377	22,981	0.0%	Shares	Sole	2024-11-14
2024-06-30	$172,357	22,981	+45.0%	Shares	Sole	2024-08-14
2024-03-31	$393,614	15,846	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.